Background: There is an ongoing debate whether stroke patients presenting with minor or moderate symptoms benefit from thrombolysis. Up until now, stroke severity on admission is typically measured with the NIHSS, and subsequently used for treatment decision. Hypothesis: Acute MRI lesion volume assessment can aid in therapy decision for iv-tPA in minor stroke. Methods:We analysed 164 patients with NIHSS 0–7 from a prospective stroke MRI registry, the 1000+ study (clinicaltrials.org NCT00715533). Patients were examined in a 3 T MRI scanner and either received (n = 62) or did not receive thrombolysis (n = 102). DWI (diffusion weighted imaging) and PI (perfusion imaging) at admission were evaluated for diffusion- perfusion mismatch. Our primar...
Background and Purpose: Currently, diffusion-weighted imaging (DWI) lesion volume is the most useful...
Background and Purpose Patients who receive intravenous (IV) tissue plasminogen activator (tPA) for ...
Background and Purpose: Before Phase III trials of acute stroke therapies, proof-of-concept MRI tria...
Background: There is an ongoing debate whether stroke patients presenting with minor or moderate sym...
There is an ongoing debate whether stroke patients presenting with minor or moderate symptoms benefi...
Background There is an ongoing debate whether stroke patients presenting with minor or moderate symp...
We hypothesized that pretreatment magnetic resonance imaging (MRI) diffusion-weighted imaging (DWI) ...
ObjectiveTreatment of patients with stroke presenting with minor deficits remains controversial, and...
Whether minor ischemic stroke (MIS) patients can benefit from intravenous thrombolysis (IVT) remains...
International audienceBACKGROUND: Whether bridging therapy (intravenous thrombolysis [IVT] followed ...
BACKGROUND AND PURPOSE: The relationship between location of occlusion and clinical outcome is poorl...
Background and Purpose—An acute mismatch on diffusion-weighted MRI (DWI) and perfusion-weighted MRI ...
Purpose: Beyond intravenous thrombolysis, evidence is lacking on acute treatment of minor stroke cau...
Background and Purpose—We compared outcome and symptomatic bleeding complications of intravenous tis...
Whether bridging therapy (intravenous thrombolysis [IVT] followed by mechanical thrombectomy) is sup...
Background and Purpose: Currently, diffusion-weighted imaging (DWI) lesion volume is the most useful...
Background and Purpose Patients who receive intravenous (IV) tissue plasminogen activator (tPA) for ...
Background and Purpose: Before Phase III trials of acute stroke therapies, proof-of-concept MRI tria...
Background: There is an ongoing debate whether stroke patients presenting with minor or moderate sym...
There is an ongoing debate whether stroke patients presenting with minor or moderate symptoms benefi...
Background There is an ongoing debate whether stroke patients presenting with minor or moderate symp...
We hypothesized that pretreatment magnetic resonance imaging (MRI) diffusion-weighted imaging (DWI) ...
ObjectiveTreatment of patients with stroke presenting with minor deficits remains controversial, and...
Whether minor ischemic stroke (MIS) patients can benefit from intravenous thrombolysis (IVT) remains...
International audienceBACKGROUND: Whether bridging therapy (intravenous thrombolysis [IVT] followed ...
BACKGROUND AND PURPOSE: The relationship between location of occlusion and clinical outcome is poorl...
Background and Purpose—An acute mismatch on diffusion-weighted MRI (DWI) and perfusion-weighted MRI ...
Purpose: Beyond intravenous thrombolysis, evidence is lacking on acute treatment of minor stroke cau...
Background and Purpose—We compared outcome and symptomatic bleeding complications of intravenous tis...
Whether bridging therapy (intravenous thrombolysis [IVT] followed by mechanical thrombectomy) is sup...
Background and Purpose: Currently, diffusion-weighted imaging (DWI) lesion volume is the most useful...
Background and Purpose Patients who receive intravenous (IV) tissue plasminogen activator (tPA) for ...
Background and Purpose: Before Phase III trials of acute stroke therapies, proof-of-concept MRI tria...